5 Growth Stocks For 2022

2. Tricida, Inc. (NASDAQ:TCDA)

Number of Hedge Fund Holders: 19

Stock Price as of Feb. 16: $9.79

Tricida, Inc. (NASDAQ:TCDA) is an American pharmaceutical company that develops drugs for kidney diseases.

19 of the 867 hedge funds part of Insider Monkey’s Q3 2021 survey also own the company’s shares.

JPMorgan set a $7 price target for the company in January 2022, citing optimism for a recent cash raise of $42 million.

Samuel Isaly’s OrbiMed Advisors is Tricida, Inc. (NASDAQ:TCDA)’s largest investor. It owns a stake of $44 million through 9.6 million shares.